Please provide your email address to receive an email when new articles are posted on . “Prior research has established the subcutaneous ICD as a reasonable alternative to the transvenous ICD in ...

The implantable defibrillator with subcutaneous leads, designed in part to minimize the risk for potentially serious lead-related complications, has reached a milestone by turning in a "noninferior" ...

Patients with intracardiac shunts might at some point require a pacemaker or an implantable cardioverter–defibrillator (ICD). These patients may have numerous thrombotic risk factors, however, and ...

A leadless intracardiac transcatheter pacing system has been designed to avoid the need for a pacemaker pocket and transvenous lead. In a prospective multicenter study without controls, a ...

Two types of implantable cardioverter defibrillators can reduce the risk of sudden cardiac death with HCM. Pacemakers and implantable loop recorders also may be options.

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins FDA approval of the Medtronic Aurora EV-ICD system includes the system's ...

NEW ORLEANS -- An investigational extravascular implantable cardioverter-defibrillator (ICD) continues to demonstrate it can appropriately shock patients and prevent sudden cardiac death, extended ...

Leadless pacemaker technology represents a significant advancement in cardiac rhythm management, eliminating the need for transvenous leads and reducing many of the complications associated with ...